News
Investors unfazed by FDA’s Covid vaccine framework
The FDA announced yesterday that it will limit access to Covid-19 vaccines to people 65 years of age and older and others who are at high risk of becoming seriously ill. It will also require manufacturers to conduct clinical trials to show whether the vaccines benefit healthy younger adults and children.
Health experts say there are legitimate questions about how much everyone still benefits from yearly COVID vaccination or ...
Moderna said on Wednesday it has withdrawn an application seeking approval for its flu and COVID combination vaccine ...
"Here is a prime example of just how influential Big Pharma still is," MAHA influencer Diana Atieh told Newsweek.
17hon MSN
The FDA announced a policy shift for COVID-19 vaccine approvals to focus on Americans considered high-risk of contracting the ...
The U.S. Food and Drug Administration on Tuesday said it plans to require new clinical trials for approval of annual COVID-19 ...
Agency will ask drugmakers for large trials for new versions of vaccines meant for healthy adults and children.
This vaccine did previously have emergency approval by the FDA for use but can now be marketed in the U.S. for use, the ...
A vaccine that helps people overcome cocaine addiction has shown signs of being safe and effective in a small trial ...
Help Register Login Login Hi, %{firstName}% Hi, %{firstName}% Games Car rental The U.S. Food and Drug Administration (FDA) ...
South Korean vaccine company SK Bioscience said it has prevailed in a lawsuit brought by Pfizer that accused it of infringing on the patent for the drugmaker's Prevnar 13 vaccine.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback